- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 2.1 EX-2.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.5 EX-10.5
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.36 EX-10.36
- 10.37 EX-10.37
- 10.38 EX-10.38
- 10.39 EX-10.39
- 10.40 EX-10.40
- 10.41 EX-10.41
- 10.42 EX-10.42
- 10.43 EX-10.43
- 10.44 EX-10.44
- 10.45 EX-10.45
- 10.46 EX-10.46
- 10.47 EX-10.47
- 10.48 EX-10.48
- 10.49 EX-10.49
- 10.50 EX-10.50
- 10.51 EX-10.51
- 10.52 EX-10.52
- 10.53 EX-10.53
- 10.54 EX-10.54
- 10.55 EX-10.55
- 10.56 EX-10.56
- 10.57 EX-10.57
- 10.58 EX-10.58
- 23.1 EX-23.1
- 23.2 EX-23.2
- 99.1 EX-99.1
- 99.3 EX-99.3
- 99.4 EX-99.4
- EX-FILING FEES Ex-filing Fees
- Download Excel data file
- View Excel data file
- 13 Mar 24 POS EX Additional exhibits for listing
- 13 Mar 24 424B3 Prospectus supplement
- 15 Feb 24 EFFECT Notice of effectiveness
- 14 Feb 24 424B3 Prospectus supplement
- 13 Feb 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 12 Feb 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
15 Dec 23 S-4 Registration of securities issued in business combination transactions
- 13 Feb 24 Registration of securities issued in business combination transactions (amended)
- 12 Feb 24 Registration of securities issued in business combination transactions (amended)
- 29 Jan 24 Registration of securities issued in business combination transactions (amended)
- 15 Dec 23 Registration of securities issued in business combination transactions
Exhibit 99.4
Consent to be Named as a Director
In connection with the filing by Homology Medicines, Inc. (the “Company”) of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto as a person who has agreed to serve as a director of the Company following its merger with Q32 Bio Inc. (which shall be known as Q32 Bio Inc.) as described in the Registration Statement. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
Dated: December 15, 2023
By: | /s/ Jodie Morrison | |
Name: | Jodie Morrison |